Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037750 | SCV000061412 | likely benign | not specified | 2021-01-26 | criteria provided, single submitter | clinical testing | The p.Leu653Phe variant in TMPO is classified as likely benign because it has been identified in 0.3% (88/30610) of South Asian chromosomes, including 1 homozygote, and in 0.03% (43/128824) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. ACMG/AMP Criteria applied: BS1. |
Invitae | RCV001087301 | SCV000561632 | likely benign | Loeys-Dietz syndrome 2 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000839110 | SCV000980992 | likely benign | not provided | 2018-05-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Advanced Laboratory Medicine, |
RCV000852685 | SCV000995394 | likely benign | Arrhythmogenic right ventricular cardiomyopathy | 2019-03-18 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000037750 | SCV003922894 | likely benign | not specified | 2023-03-01 | criteria provided, single submitter | clinical testing | |
Dept of Medical Biology, |
RCV003318343 | SCV004021985 | benign | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: BS1, BS2 |